《公司業績》恆發光學(01134.HK)去年盈轉虧蝕1,340萬元 不派息
恆發光學(01134.HK)公布截至去年底止全年業績顯示,錄得盈轉虧蝕1,340.2萬元,上年同期盈利837.7萬元。基本每股盈利2.68仙。不派末期息。
期內,收入按年減少約14.3%至約3.54億元。有關減少主要由於全球爆發COVID-19對集團的出口銷售造成不利影響,使銷量減少及銷售訂單延誤,導致光學眼鏡架及太陽眼鏡銷量減少。毛利按年減少約37.6%至約6,014萬元。整體毛利率由上年約23.3%大幅下跌至17%。(ta/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.